Company
Senovia Biosciences
Senovia develops drugs that deliver the benefits of ketosis, without the diet. The company is privately held.
Leadership and scientific advisers
Joel R. Anderson II
Founder and Chief Executive Officer
Dominic D'Agostino, PhD
Scientific adviser
Bradlee Heckmann, PhD
Scientific adviser
Investors
Investor inquiries
Accredited and institutional investors may request company information, which is shared privately and directly by the company. Nothing on this website is an offer to sell, or a solicitation of an offer to buy, any security.